what's glp-1 Medications Infographic GLP-1 Drug Side Effects May
Description
Patients with T2DM, persons at risk for AD, had a significantly lower associated risk of AD after administered exenatide, liraglutide and dulaglutide (83)
Mounjaro is FDA-approved for type 2 diabetes (FDA-approved 2022) and is administered as a once-weekly subcutaneous injection
And it makes sense
GLP-1 RAs are designed to last much longer, from the time you take one dose until the time the next is due
Diabetes Obes Metab 15: 713720, 2013
It may also serve as a more effective oral GLP-1 than Rybelsus the other current oral GLP-1 for treating diabetes
